![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Signa S.a. De C.v. Toluca Mx, based in Mexico, is a pharmaceutical company that stands out with its certifications from FDA.
One of their significant offerings is Imatinib mesilate, supported by a 'Expired' Certificate of Suitability (CEP) with the number R0-CEP 2015-251 - Rev 03
This Chemical Type CEP, issued on February 14, 2019, remains in force until November 25, 2021, ensuring its reliability within the pharmaceutical industry.
Substance Number 2736 associated with this CEP further emphasizes